These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 6760793
1. The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy. Das PK, Ibrahim AA, Binkhuysen F, Thi Hué P, Qui TH, Rangarajan R, Ruitenberg EJ. Ann Immunol (Paris); 1982; 133D(1):41-59. PubMed ID: 6760793 [No Abstract] [Full Text] [Related]
3. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Rada EM, Aranzazu N, Convit J. Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162 [No Abstract] [Full Text] [Related]
4. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy. Melsom R, Naafs B, Harboe M, Closs O. Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205 [No Abstract] [Full Text] [Related]
8. Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria. Harboe M, Mshana RN, Closs O, Kronvall G, Axelsen NH. Scand J Immunol; 1979 Mar; 9(2):115-24. PubMed ID: 106465 [Abstract] [Full Text] [Related]
9. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS. Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [Abstract] [Full Text] [Related]
10. General ideas concerning a vaccine against leprosy: a basis for discussion during the Eleventh International Leprosy Congress. Convit J, Ulrich M. Int J Lepr Other Mycobact Dis; 1978 Sep; 46(1):61-3. PubMed ID: 348611 [No Abstract] [Full Text] [Related]
11. The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Britton WJ, Garsia RJ, Hellqvist L, Watson JD, Basten A. Lepr Rev; 1986 Dec; 57 Suppl 2():67-75. PubMed ID: 3553805 [No Abstract] [Full Text] [Related]
13. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Myrvang B, Godal T, Ridley DS, Fröland SS, Song YK. Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777 [Abstract] [Full Text] [Related]
14. Rationales for vaccines against leprosy. Bloom BR. Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414 [No Abstract] [Full Text] [Related]
15. Significance of antibody studies in leprosy and experimental models of the disease. Harboe M. Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):342-50. PubMed ID: 6754640 [No Abstract] [Full Text] [Related]
16. A component of Mycobacterium leprae as a serodiagnostic tool for leprosy. Ranade A, Mahadevan PR. Indian J Biochem Biophys; 1988 Dec; 25(6):554-9. PubMed ID: 3076580 [No Abstract] [Full Text] [Related]
17. Comparison of thermostable macromolecular antigens from leprosy-associated bacteria. Baelden MC, Bouckaert AE, Grégoire D, van de Poele M, Coene M. Can J Microbiol; 1994 Jun; 40(6):508-12. PubMed ID: 8050070 [Abstract] [Full Text] [Related]
18. Regarding analysis of vaccines. Convit J. Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):576-7. PubMed ID: 8642226 [No Abstract] [Full Text] [Related]
19. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients. Moudgil KD, Gupta SK, Naraynan PR, Srivastava LM, Mishra RS, Talwar GP. Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751 [Abstract] [Full Text] [Related]
20. Cross reactivity of Mycobacterium laprae and BCG. A report on further studies. Goihman-Yahr M, Convit J. Int J Lepr Other Mycobact Dis; 1972 Nov; 40(1):62-7. PubMed ID: 4562385 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]